ENXTPA:ABVXBiotechs
Abivax (ENXTPA:ABVX) Stock Sinks As Losses Deepen Despite Late Stage Progress
ABIVAX Société Anonyme entered this earnings report with a strong reputation for future growth and a share price that has been volatile but still relatively well supported, even as the stock declined 15.1% over the past month and 7.9% over the last week. The headline today is not the revenue line, which sits around €1.2 million for the quarter. The main story is the deepening loss, with Q2 net income showing a triple digit million euro deficit and basic earnings per share firmly in the red...